Effect of preoperative administration of allopurinol in patients undergoing surgery for valvular heart diseases

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 1, 2010, Pages 86-90

  Talwar, Sachin ^a   Sandeep, Janardhan Alamanda ^a   Choudhary, Shiv Kumar ^a   Velayoudham, Devagourou ^a   Lakshmy, Ramakrishnan ^a   Kasthuri, Jeeva Mani ^a   Kumar, Arkalgud Sampath ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Allopurinol; Cardiopulmonary bypass; Open heart surgery; Valvular heart diseases

Indexed keywords

ALLOPURINOL; CREATINE KINASE MB; PLACEBO; TROPONIN T;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ANALYSIS; FEMALE; HEART OUTPUT; HEART RHYTHM; HUMAN; INOTROPISM; LENGTH OF STAY; MALE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SURGICAL MORTALITY; VALVULAR HEART DISEASE;

ADULT; ALLOPURINOL; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CREATINE KINASE, MB FORM; EPIDEMIOLOGIC METHODS; FEMALE; FREE RADICAL SCAVENGERS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREANESTHETIC MEDICATION; RESPIRATION, ARTIFICIAL; TROPONIN T; YOUNG ADULT;

EID: 77953286310     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.01.027     Document Type: Article

References (12)

1. Asimakopoulos G. Systemic inflammation and cardiac surgery: an update. Perfusion 16 (2001) 353-360
2. Hill G.E. Cardiopulmonary bypass-induced inflammation: is it important?. J Cardiothorac Vasc Anesth 12 2 Suppl. 1 (1998) 21-25
3. Iskesen I., Saribulbul O., Cerrahoglu M., Onur E., Destan B., and Sirin B.H. Pentoxifylline affects cytokine reaction in cardiopulmonary bypass. Heart Surg Forum 9 (2006) E883-E887
4. Castelli P., Condemi A.M., Brambillasca C., Fundarò P., Botta M., Lemma M., Vanelli P., Santoli C., Gatti S., and Riva E. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol 25 (1995) 119-125
5. Movahed A., Nair K.G., Ashavaid T.F., and Kumar P. Free radical generation and the role of allopurinol as a cardio protective agent during coronary artery bypass grafting surgery. Can J Cardiol 12 (1996) 138-144
6. John F., Rhodes M.D., Andrew D., Blaufox M.D., Howard S., and Seiden M.D. Cardiac arrest in infants after congenital heart surgery. Circulation 100 19 Suppl. (1999) II 194
7. Weimert N.A., Tanke W.F., and Sims J.J. Allopurinol as a cardioprotectant during coronary artery bypasses graft surgery. Ann Pharmacother 37 (2003) 1708-1711
8. Rashid M.A., and William-Olsson G. Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg 52 July (1991) 127-130
9. Coghlan J.G., Flitter W.D., Clutton S.M., Panda R., Daly R., Wright G., Ilsley C.D., and Slater T.F. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 107 (1994) 248-256
10. Angdin M., Settergren G., Starkopf J., Zilmer M., Zilmer K., and Vaage J. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 314-320
11. Hadjinikolaou L., Alexiou C., Cohen A.S., Standbridge Rde L., McColl A.J., and Richmond W. Early changes in plasma antioxidant and lipid peroxidation levels following coronary artery bypass surgery: a complex response. J Cardiothorac Vasc Anesth 7 (1993) 674-678
12. Nesher N., Alghamdi A.A., Singh S.K., Sever J.Y., Christakis G.T., Goldman B.S., Cohen G.N., Moussa F., and Fremes S.E. Troponin after cardiac surgery: a predictor or a phenomenon?. Ann Thorac Surg 85 (2008) 1348-1354